Direct comparison of ten quantitative fecal immunochemical tests for hemoglobin stability in colorectal cancer screening

被引:19
|
作者
Gies, Anton [1 ,2 ,3 ]
Cuk, Katarina [4 ]
Schrotz-King, Petra [1 ,2 ]
Brenner, Hermann [1 ,2 ,4 ,5 ]
机构
[1] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany
[2] Natl Ctr Tumor Dis NCT, Heidelberg, Germany
[3] Heidelberg Univ, Med Fac Heidelberg, Heidelberg, Germany
[4] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany
[5] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany
关键词
OCCULT BLOOD-TESTS; DIAGNOSTIC PERFORMANCE; AMBIENT-TEMPERATURE; SAMPLE RETURN; METAANALYSIS; POPULATION; TRIAL; RATES;
D O I
10.1038/s41424-018-0035-2
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objectives: To systematically investigate and directly compare, for the first time, the sample stability of a large number of quantitative fecal immunochemical tests (FITs) at different storage conditions. Methods: Stool samples were obtained from participants of the German screening colonoscopy program between 2005 and 2010. After an initial FIT-based hemoglobin (Hb) measurement, stool samples were kept frozen at -80 degrees C until analysis. Twenty randomly selected participants with initial measurements ranging from 10 to 100 mu g Hb/g feces were included. Ten quantitative FITs were investigated in parallel. A defined stool amount was extracted using each manufacturer's brand-specific fecal sampling device and stored at 5 degrees C, 20 degrees C, and 35 degrees C, respectively. After 1, 4, 5, and 7 days, the samples were analyzed blinded. Median fecal Hb concentrations and positivity rates were calculated. Results: Mean age of the participants was 67 years (range: 56-80 years) and 60% were male. The most advanced finding at screening colposcopy was advanced adenoma in five and non-advanced adenoma in eight cases. Hyperplastic polyps were found in two participants and five participants were without any findings. At 5 degrees C storage temperature, almost all FITs showed fairly stable results throughout the 7-day observation period. At 20 degrees C, most FITs still showed fairly stable results over 4 days, whereas positivity rates significantly declined from day 4 on for most FITs at 35 degrees C. Major differences regarding the sample stability between FITs were observed. Conclusion: FIT-specific Hb decay according to ambient temperature and time period between sampling and test evaluation requires careful consideration in the design of FIT-based screening programs.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Effects of fecal sampling on preanalytical and analytical phases in quantitative fecal immunochemical tests for hemoglobin
    Rapi, Stefano
    Berardi, Margherita
    Cellai, Filippo
    Ciattini, Samuele
    Chelazzi, Laura
    Ognibene, Agostino
    Rubeca, Tiziana
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 2017, 32 (03): : E261 - E266
  • [32] Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing
    Liu, Po-Hong
    Nair, Rasmi G.
    Skinner, Celette Sugg
    Murphy, Caitlin C.
    Kim, Eric J.
    Ortiz, Cynthia
    Wang, Lei
    Hu, Ellen
    Lykken, Jacquelyn M.
    Levin, Theodore R.
    Green, Beverly B.
    Hahn, Erin E.
    Santini, Noel
    Halm, Ethan A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2024, 33 (02) : 215 - 223
  • [33] Results of Fecal Immunochemical Tests for Colorectal Cancer Screening Not Affected by NSAIDs, Aspirin, or Anticoagulants
    Ebell, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2020, 101 (07) : 435 - 435
  • [34] A Systematic Review on Diagnostic Test Accuracy of Fecal Immunochemical Tests for Colorectal Cancer Screening
    van Roon, Aafke H.
    van Dam, Leonie
    Arends, Lidia R.
    Zauber, Ann G.
    Young, Graeme P.
    van Ballegooijen, Marjolein
    Habbema, Dik F.
    van Leerdam, Monique E.
    Steyerberg, Ewout W.
    Kuipers, Ernst J.
    GASTROENTEROLOGY, 2014, 146 (05) : S409 - S410
  • [35] Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program
    Wieten, Els
    de Klerk, Clasine M.
    van der Steen, Annemieke
    Ramakers, Christian R.
    Kuipers, Ernst J.
    Hansen, Bettina E.
    Lansdorp-Vogelaar, Iris
    Bossuyt, Patrick M.
    Dekker, Evelien
    Spaander, Manon C. W.
    GASTROENTEROLOGY, 2018, 155 (05) : 1392 - +
  • [36] Effects of Oral Anticoagulants and Aspirin on Performance of Fecal Immunochemical Tests in Colorectal Cancer Screening
    Randel, Kristin Ranheim
    Botteri, Edoardo
    Romsta, Katrine Maria Kauczynska
    Frigstad, Svein Oskar
    Bretthauer, Michael
    Hoff, Geir
    de Lange, Thomas
    Holme, Oyvind
    GASTROENTEROLOGY, 2019, 156 (06) : 1642 - +
  • [37] Colorectal Cancer Screening: Fecal immunochemical Test or Sigmoidoscopy?
    Hofmann-Assmus, Marion
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2021, 59 (07): : 626 - 628
  • [38] Making the best use of quantitative fecal immunochemical test results in colorectal cancer screening
    Brenner, Hermann
    Hoffmeister, Michael
    JOURNAL OF INTERNAL MEDICINE, 2024, 296 (02) : 118 - 120
  • [39] Optimizing Fecal Immunochemical Testing For Colorectal Cancer Screening
    Schreuders, Eline H.
    Wieten, Els
    Kuipers, Ernst J.
    Spaander, Manon C. W.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2017, 15 (10) : 1498 - 1499
  • [40] Colorectal cancer screening with fecal immunochemical testing in Nigeria
    Alatise, Olusegun, I
    Dare, Anna J.
    Kingham, T. Peter
    LANCET GLOBAL HEALTH, 2022, 10 (11): : E1562 - E1562